Viewing nowAverin Tablet 4 mg (Glimepiride)
Glimepiride 4mg
Tablet · Prescription medication
Huons Co., Ltd.

MFDS item code 200704614 · Notified 2007.04.20 · Insurance code 670601450
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone, and in cases where blood sugar control is difficult with oral hypoglycemic agents, it can be combined with insulin. Additionally, it is used in treatment when sulfonylurea or metformin monotherapy is insufficient. This approach helps improve blood sugar control and aids in diabetes management.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Take this medicine orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combining this medicine with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the amount of this medicine needed may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering medicine to this medicine There is no exact dose equivalence between this medicine and other oral glucose-lowering medicines. When switching from another oral glucose-lowering medicine to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the medicine previously administered. 4) Dose monitoring and adjustment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a comatose state. Also, it should not be administered to patients who have had allergic reactions to this drug or similar components, those with severe liver or kidney dysfunction, or women who are pregnant or breastfeeding. In cases of severe infection or post-operative situations, insulin therapy is recommended, and caution should be exercised for patients with gastrointestinal disorders such as diarrhea or vomiting due to the risk of hypoglycemia. Patients with genetic problems like lactose intolerance should also avoid this medication. During the initial dosing period, there is an increased risk of hypoglycemia, so blood sugar should be monitored frequently, especially in elderly patients or those with poor nutritional status or irregular eating, and in patients with compromised kidney or liver function. Additionally, since there can be interactions with other medications, it is essential to inform your doctor or pharmacist about all medications you are taking. This medication can cause hypoglycemia, which may manifest as headaches, hunger, dizziness, confusion, and in severe cases, loss of consciousness, so immediate intake of sugar or consultation with healthcare professionals is required if symptoms occur. Vision disturbances or gastrointestinal symptoms, liver dysfunction, blood abnormalities, and allergic reactions have also been reported, and patients should inform their doctor immediately if any unusual symptoms arise. While taking this medication, it is important to maintain regular meals and exercise, and to continuously monitor blood sugar control. Women who are pregnant or breastfeeding should avoid this medication and transition to insulin therapy for safety. Safety and efficacy in children have not been established, and dosage adjustments may be necessary for the elderly due to declining kidney function. In cases of overdose, severe hypoglycemia may occur, necessitating immediate emergency treatment and should be stored out of the reach of children.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, speech disturbance, aphasia, visual impairment, tremor, partial paralysis, sensory disturbance, dizziness, weakness, loss of self-control, temporary mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, shortness of breath, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbance, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial swelling, erectile dysfunction, flushing of the face, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is best maintained at room temperature between 1 to 30 degrees Celsius.
Light blue elongated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 4mg
Tablet · Prescription medication
Huons Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.